TIM
ALXN

Tortoise Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Tortoise Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12
Closed -$1K – 627
2019
Q3 		$1K Hold
12
– – ﹤0.01% 588
2019
Q2 		$2K Hold
12
– – ﹤0.01% 581
2019
Q1 		$2K Buy
+12
New +$1.49K ﹤0.01% 575

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tortoise Investment Management's ALXN Position: Q4 2019 in Review

Tortoise Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q4 2019, closing a stake of 12 shares — an estimated $1K sold.

Tortoise Investment Management first reported a position in ALXN in Q1 2019 and held it in 3 quarters. The position peaked at $2K in Q2 2019. 667 funds tracked by Wall St. Rank hold ALXN as of Q4 2019.

  • Tortoise Investment Management reported no remaining Alexion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Tortoise Investment Management sold 12 Alexion Pharmaceuticals shares in Q4 2019, an estimated $1K.
  • Tortoise Investment Management first reported a position in Alexion Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Tortoise Investment Management's Alexion Pharmaceuticals position peaked at $2K in Q2 2019.
  • 667 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2019.

Based on Tortoise Investment Management's 13F filing for Q4 2019, filed 6 Feb 2020.